Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

A woman had a rare, non-cancerous skin growth on her face, which was removed and did not come back after a year.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Azathioprine may help treat severe alopecia areata, but more research is needed.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Twins had rare skin cysts likely due to genetics.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

A unique case showed a rare combination of two types of lichen planus on the face.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

A new genetic change in the keratin 10 gene caused a skin condition called ichthyosis hystrix in a father and his daughter.